Oost et al. (50) found that in type 1 diabetes patients receiving high doses of insulin therapy, hypomagnesemia may exacerbate insulin resistance, thereby affecting glycemic control and inflammation levels. This evidence concerns the gene INS and type 1 diabetes mellitus.